Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Catharina Larsson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Anatomy

Disorders

Phenomena

Nucleic Acid Hybridization

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Tumor Suppressor Genes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Sofiadis Anastasios; Tani Edneia; Foukakis Theodoros; Kjellman Petra; Skoog Lambert; Höög Anders; Wallin Göran; Zedenius Jan; Larsson Catharina
Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling T M L; Ignatius J; Aaltonen L A; Leisti J; Salmela P I
Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Fotoohi Alan Kambiz; Assaraf Yehuda G; Moshfegh Ali; Hashemi Jamileh; Jansen Gerrit; Peters Godefridus J; Larsson Catharina; Albertioni Freidoun
Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Catharina Larsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sofiadis Anastasios; Tani Edneia; Foukakis Theodoros; Kjellman Petra; Skoog Lambert; Höög Anders; Wallin Göran; Zedenius Jan; Larsson Catharina
Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
International journal of oncology 2009;35(2):369-74.
2009: Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling T M L; Ignatius J; Aaltonen L A; Leisti J; Salmela P I
Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Journal of endocrinological investigation 2009;32(6):512-8.
2009: Fotoohi Alan Kambiz; Assaraf Yehuda G; Moshfegh Ali; Hashemi Jamileh; Jansen Gerrit; Peters Godefridus J; Larsson Catharina; Albertioni Freidoun
Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
Biochemical pharmacology 2009;77(8):1410-7.
2009: Juhlin C Christofer; Haglund Felix; Villablanca Andrea; Forsberg Lars; Sandelin Kerstin; Bränström Robert; Larsson Catharina; Höög Anders
Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.
International journal of oncology 2009;34(2):481-92.
2008: Lee Jia-Jing; Geli Janos; Larsson Catharina; Wallin Göran; Karimi Mohsen; Zedenius Jan; Höög Anders; Foukakis Theodoros
Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.
International journal of oncology 2008;33(4):861-9.
2008: Lee Jia-Jing; Au Amy Y M; Foukakis Theodoros; Barbaro Michela; Kiss Nimrod; Clifton-Bligh Roderick; Staaf Johan; Borg Ake; Delbridge Leigh; Robinson Bruce G; Wallin Göran; Höög Anders; Larsson Catharina
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
Endocrine-related cancer 2008;15(3):801-15.
2008: Geli Janos; Kogner Per; Lanner Fredrik; Natalishvili Natalia; Juhlin Christofer; Kiss Nimrod; Clark Geoffrey J; Ekström Tomas J; Farnebo Filip; Larsson Catharina
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
International journal of cancer. Journal international du cancer 2008;123(2):389-94.
2008: Kiss N B; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström T J; Bäckdahl M; Larsson C
Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
Endocrine-related cancer 2008;15(2):609-21.
2008: Lu Ming; Forsberg Lars; Höög Anders; Juhlin Christofer C; Vukojevic Vladana; Larsson Catharina; Conigrave Arthur D; Delbridge Leigh W; Gill Anthony; Bark Christina; Farnebo Lars-Ove; Bränström Robert
Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue.
Molecular and cellular endocrinology 2008;287(1-2):72-80.
2008: Lu Shasha; Zhao Chen; Zhao Kanxing; Li Ningdong; Larsson Catharina
Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3.
Archives of ophthalmology 2008;126(3):388-94.
2008: Thelander Emma Flordal; Ichimura Koichi; Corcoran Martin; Barbany Gisela; Nordgren Ann; Heyman Mats; Berglund Mattias; Mungall Andy; Rosenquist Richard; Collins V Peter; Grandér Dan; Larsson Catharina; Lagercrantz Svetlana
Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia.
Leukemia & lymphoma 2008;49(3):477-87.
2007: Flordal Thelander Emma; Ichimura Koichi; Collins V Peter; Walsh Sarah H; Barbany Gisela; Hagberg Anette; Laurell Anna; Rosenquist Richard; Larsson Catharina; Lagercrantz Svetlana
Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.
Leukemia research 2007;31(9):1219-30.
2007: Juhlin C C; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
Endocrine-related cancer 2007;14(2):501-12.
2007: Foukakis Theodoros; Gusnanto Arief; Au Amy Y M; Höög Anders; Lui Weng-Onn; Larsson Catharina; Wallin Göran; Zedenius Jan
A PCR-based expression signature of malignancy in follicular thyroid tumors.
Endocrine-related cancer 2007;14(2):381-91.
2007: Lee Jia-Jing; Foukakis Theodoros; Hashemi Jamileh; Grimelius Lars; Heldin Nils-Erik; Wallin Göran; Rudduck Christina; Lui Weng-Onn; Höög Anders; Larsson Catharina
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models.
Thyroid : official journal of the American Thyroid Association 2007;17(4):289-301.
2007: Geli Janos; Kiss Nimrod; Lanner Fredrik; Foukakis Theodoros; Natalishvili Natalia; Larsson Olle; Kogner Per; Höög Anders; Clark Geoffrey J; Ekström Tomas J; Bäckdahl Martin; Farnebo Filip; Larsson Catharina
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
Endocrine-related cancer 2007;14(1):125-34.
2007: Berglund Mattias; Enblad Gunilla; Thunberg Ulf; Amini Rose-Marie; Sundström Christer; Roos Göran; Erlanson Martin; Rosenquist Richard; Larsson Catharina; Lagercrantz Svetlana
Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(1):63-75.
2007: Lu Shasha; Zhao Chen; Jiao Hong; Kere Juha; Tang Xin; Zhao Feng; Zhang Xiumei; Zhao Kanxing; Larsson Catharina
Two Chinese families with pulverulent congenital cataracts and deltaG91 CRYBA1 mutations.
Molecular vision 2007;13():1154-60.
2006: Forsberg Lars; Larsson Catharina; Sofiadis Anastasios; Lewensohn Rolf; Höög Anders; Lehtiö Janne
Pre-fractionation of archival frozen tumours for proteomics applications.
Journal of biotechnology 2006;126(4):582-6.
2006: Lee Jia-Jing; Larsson Catharina; Lui Weng-Onn; Höög Anders; Von Euler Henrik
A dog pedigree with familial medullary thyroid cancer.
International journal of oncology 2006;29(5):1173-82.
2006: Weng Wen-Hui; Claviez Alexander; Krams Matthias; Hashemi Jamileh; Larsson Olle; Larsson Catharina; Suttorp Meinolf
A 10-year-old girl with bifocal synovial sarcoma.
The lancet oncology 2006;7(7):605-7.
2006: Zhao Chen; Lu Shasha; Zhou Xiaolei; Zhang Xiumei; Zhao Kanxing; Larsson Catharina
A novel locus (RP33) for autosomal dominant retinitis pigmentosa mapping to chromosomal region 2cen-q12.1.
Human genetics 2006;119(6):617-23.
2006: Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Loss of parafibromin expression in a subset of parathyroid adenomas.
Endocrine-related cancer 2006;13(2):509-23.
2006: Vasilcanu D; Weng W-H; Girnita A; Lui W-O; Vasilcanu R; Axelson M; Larsson O; Larsson C; Girnita L
The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection.
Oncogene 2006;25(22):3186-95.
2006: Foukakis Theodoros; Au Amy Y M; Wallin Göran; Geli Janos; Forsberg Lars; Clifton-Bligh Roderick; Robinson Bruce G; Lui Weng-Onn; Zedenius Jan; Larsson Catharina
The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.
The Journal of clinical endocrinology and metabolism 2006;91(3):1143-9.
2006: Jarbo Caroline; Buckley Patrick G; Piotrowski Arkadiusz; Mantripragada Kiran K; Benetkiewicz Magdalena; Diaz de Ståhl Teresita; Langford Cordelia F; Gregory Simon G; Dralle Henning; Gimm Oliver; Bäckdahl Martin; Geli Janos; Larsson Catharina; Westin Gunnar; Akerström Göran; Dumanski Jan P
Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.
International journal of cancer. Journal international du cancer 2006;118(5):1159-64.
2006: Aldred Michael J; Talacko Anna A; Savarirayan Ravi; Murdolo Vince; Mills Alan E; Radden Bryan G; Alimov Andrei; Villablanca Andrea; Larsson Catharina
Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2006;101(2):212-8.
2006: Pang See-Tong; Weng Wen-Hui; Flores-Morales Amilcar; Johansson Björn; Pourian Mohammad R; Nilsson Peter; Pousette Ake; Larsson Catharina; Norstedt Gunnar
Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.
The Prostate 2006;66(2):157-72.
2006: Fryknäs Mårten; Wickenberg-Bolin Ulrika; Göransson Hanna; Gustafsson Mats G; Foukakis Theodoros; Lee Jia-Jing; Landegren Ulf; Höög Anders; Larsson Catharina; Grimelius Lars; Wallin Göran; Pettersson Ulf; Isaksson Anders
Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(4):211-20.
2005: Weng Wen-Hui; Ahlén Jan; Aström Kristina; Lui Weng-Onn; Larsson Catharina
Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6198-204.
2005: Mansouri Mahmoud Reza; Marklund Lena; Gustavsson Peter; Davey Edward; Carlsson Birgit; Larsson Catharina; White Irene; Gustavson Karl-Henrik; Dahl Niklas
Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation.
European journal of human genetics : EJHG 2005;13(8):970-7.
2005: Geli Janos; Nord Brita; Frisk Tony; Edström Elder Elisabeth; Ekström Tomas J; Carling Tobias; Bäckdahl Martin; Larsson Catharina
Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.
International journal of oncology 2005;26(5):1385-91.
2005: Chang Cherry Tzu-Ru; Weng Wen-Hui; Chou Andy Shau-Bin; Chuang Cheng-Keng; Porwit-McDonald Anja; Pang See-Tong; Larsson Catharina; Liao Shuen-Kuei
Immunophenotypic and molecular cytogenetic features of the cell line UP-LN1 established from a lymph node metastasis of a poorly-differentiated carcinoma.
Anticancer research 2005;25(2A):683-91.
2005: Forsberg Lars; Björck Erik; Hashemi Jamileh; Zedenius Jan; Höög Anders; Farnebo Lars-Ove; Reimers Mark; Larsson Catharina
Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(3):459-70.
2005: Elder Elisabeth Edström; Elder Grahame; Larsson Catharina
Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.
Journal of surgical oncology 2005;89(3):193-201.
2005: Thelander Emma Flordal; Walsh Sarah H; Thorsélius Mia; Laurell Anna; Landgren Ola; Larsson Catharina; Rosenquist Richard; Lagercrantz Svetlana
Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(3):331-9.
2005: Lui Weng-Onn; Foukakis Theodoros; Lidén Johan; Thoppe Srinivasan R; Dwight Trisha; Höög Anders; Zedenius Jan; Wallin Göran; Reimers Mark; Larsson Catharina
Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.
Oncogene 2005;24(8):1467-76.
2005: Ahlén Jan; Wejde Johan; Brosjö Otte; von Rosen Anette; Weng Wen-Hui; Girnita Leonard; Larsson Olle; Larsson Catharina
Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):206-16.
2005: Foukakis Theodoros; Thoppe Srinivasan R; Lagercrantz Svetlana; Dwight Trisha; Weng Wen-Hui; Svensson Ann; Höög Anders; Zedenius Jan; Wallin Göran; Lui Weng-Onn; Larsson Catharina
Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
International journal of oncology 2005;26(1):141-9.
2005: Weng Wen-Hui; Lerner Mikael; Grandér Dan; Ahlén Jan; Villablanca Andrea; Pang See-Tong; Wejde Johan; Lui Weng-Onn; Larsson Catharina
Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity.
International journal of oncology 2005;26(1):5-16.
2004: Alimov Andrei; Sundelin Birgitta; Bergerheim Ulf; Pavlenko Maxim; Pisa Pavel; Zetterberg Anders; Larsson Catharina; Lagercrantz Svetlana
Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.
International journal of oncology 2004;25(4):955-60.
2004: Corcoran Martin M; Hammarsund Marianne; Zhu Chaoyong; Lerner Mikael; Kapanadze Bagrat; Wilson Bill; Larsson Catharina; Forsberg Lars; Ibbotson Rachel E; Einhorn Stefan; Oscier David G; Grandér Dan; Sangfelt Olle
DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse.
Genes, chromosomes & cancer 2004;40(4):285-97.
2004: Alimov Andrei; Sundelin Birgitta; Wang Naining; Larsson Catharina; Bergerheim Ulf
Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.
International journal of oncology 2004;25(1):179-85.
2004: Weng Wen-Hui; Wejde Johan; Ahlén Jan; Pang See-Tong; Lui Weng-Onn; Larsson Catharina
Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.
Cancer genetics and cytogenetics 2004;150(1):27-32.
2004: Villablanca A; Calender A; Forsberg L; Höög A; Cheng J-D; Petillo D; Bauters C; Kahnoski K; Ebeling T; Salmela P; Richardson A-L; Delbridge L; Meyrier A; Proye C; Carpten J D; Teh B T; Robinson B G; Larsson C
Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP).
Journal of medical genetics 2004;41(3):e32.
2003: Välimäki Stiina; Höög Anders; Larsson Catharina; Farnebo Lars-Ove; Bränström Robert
High extracellular Ca2+ hyperpolarizes human parathyroid cells via Ca(2+)-activated K+ channels.
The Journal of biological chemistry 2003;278(50):49685-90.
2003: Chen Jindong; Lui Weng-Onn; Vos Michele D; Clark Geoffrey J; Takahashi Masayuki; Schoumans Jacqueline; Khoo Sok Kean; Petillo David; Lavery Todd; Sugimura Jun; Astuti Dewi; Zhang Chun; Kagawa Susumu; Maher Eamonn R; Larsson Catharina; Alberts Arthur S; Kanayama Hiro-omi; Teh Bin Tean
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas.
Cancer cell 2003;4(5):405-13.
2003: Shattuck Trisha M; Välimäki Stiina; Obara Takao; Gaz Randall D; Clark Orlo H; Shoback Dolores; Wierman Margaret E; Tojo Katsuyoshi; Robbins Christiane M; Carpten John D; Farnebo Lars-Ove; Larsson Catharina; Arnold Andrew
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
The New England journal of medicine 2003;349(18):1722-9.
2003: Dwight Trisha; Thoppe Srinivasan R; Foukakis Theodoros; Lui Weng O; Wallin Göran; Höög Anders; Frisk Tony; Larsson Catharina; Zedenius Jan
Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.
The Journal of clinical endocrinology and metabolism 2003;88(9):4440-5.
2003: Ahlén Jan; Weng Wendy W-H; Brosjö Otte; Von Rosen Anette; Larsson Olle; Larsson Catharina
Evaluation of immunohistochemical parameters as prognostic markers in malignant fibrous histiocytoma.
Oncology reports 2003;10(5):1641-5.
2003: Weng W-H; Ahlén J; Lui W-O; Brosjö O; Pang S-T; Von Rosen A; Auer G; Larsson O; Larsson C
Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis.
British journal of cancer 2003;89(4):720-6.
2003: Kjellman Petra; Wallin Göran; Höög Anders; Auer Gert; Larsson Catharina; Zedenius Jan
MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2003;13(4):371-80.
2003: Elder E Edström; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(3):246-55.
2003: Berglund Mattias; Flordal Emma; Gullander Jacob; Lui Weng-Onn; Larsson Catharina; Lagercrantz Svetlana; Enblad Gunilla
Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma.
Cancer genetics and cytogenetics 2003;141(1):43-8.
2002: Flordal Emma; Berglund Mattias; Rosenquist Richard; Erlanson Martin; Enblad Gunilla; Roos Göran; Larsson Catharina; Lagercrantz Svetlana
Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization.
Cancer genetics and cytogenetics 2002;139(1):38-43.
2002: Dwight Trisha; Nelson Anne E; Theodosopoulos George; Richardson Anne Louise; Learoyd Diana L; Philips Jeanette; Delbridge Leigh; Zedenius Jan; Teh Bin T; Larsson Catharina; Marsh Deborah J; Robinson Bruce G
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.
The American journal of pathology 2002;161(4):1299-306.
2002: Välimäki S; Forsberg L; Farnebo L-O; Larsson C
Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
International journal of oncology 2002;21(4):727-35.
2002: Villablanca Andrea; Wassif Wassif S; Smith Thomas; Höög Anders; Vierimaa Outi; Kassem Moustapha; Dwight Trisha; Forsberg Lars; Du Quan; Learoyd Diana; Jones Keston; Stranks Steve; Juhlin Claes; Teh Bin Tean; Carling Tobias; Robinson Bruce; Larsson Catharina
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2002;147(3):313-22.
2002: Frisk Tony; Foukakis Theodoris; Dwight Trisha; Lundberg Jonas; Höög Anders; Wallin Göran; Eng Charis; Zedenius Jan; Larsson Catharina
Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Genes, chromosomes & cancer 2002;35(1):74-80.
2002: Berglund Mattias; Enblad Gunilla; Flordal Emma; Lui Weng-Onn; Backlin Carin; Thunberg Ulf; Sundström Christer; Roos Göran; Allander Susanne V; Erlanson Martin; Rosenquist Richard; Larsson Catharina; Lagercrantz Svetlana
Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(8):807-16.
2002: Edström Elder Elisabeth; Nord Brita; Carling Tobias; Juhlin Claes; Bäckdahl Martin; Höög Anders; Larsson Catharina
Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma.
World journal of surgery 2002;26(8):965-71.
2002: Kytölä Soili; Nord Brita; Elder Elisabeth Edström; Carling Tobias; Kjellman Magnus; Cedermark Björn; Juhlin Claes; Höög Anders; Isola Jorma; Larsson Catharina
Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas.
Genes, chromosomes & cancer 2002;34(3):325-32.
2002: Yang Ke; Lui Weng-Onn; Xie Yuntao; Zhang Anju; Skytting Björn; Mandahl Nils; Larsson Catharina; Larsson Olle
Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.
Oncogene 2002;21(26):4181-90.
2002: Roshani Leyla; Fujioka Kaoru; Auer Gert; Kjellman Magnus; Lagercrantz Svetlana; Larsson Catharina
Aberrations of centrosomes in adrenocortical tumors.
International journal of oncology 2002;20(6):1161-5.
2002: Dwight T; Kytölä S; Teh B T; Theodosopoulos G; Richardson A L; Philips J; Twigg S; Delbridge L; Marsh D J; Nelson A E; Larsson C; Robinson B G
Genetic analysis of lithium-associated parathyroid tumors.
European journal of endocrinology / European Federation of Endocrine Societies 2002;146(5):619-27.
2002: Villablanca Andrea; Farnebo Filip; Teh Bin Tean; Farnebo Lars-Ove; Höög Anders; Larsson Catharina
Genetic and clinical characterization of sporadic cystic parathyroid tumours.
Clinical endocrinology 2002;56(2):261-9.
2002: Lui Weng Onn; Chen Jindong; Gläsker Sven; Bender Bernhad U; Madura Casey; Khoo Sok Kean; Kort Eric; Larsson Catharina; Neumann Harmut P H; Teh Bin Tean
Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.
Oncogene 2002;21(7):1117-22.
2001: Forsberg L; Zablewska B; Piehl F; Weber G; Lagercrantz S; Gaudray P; Höög C; Larsson C
Differential expression of multiple alternative spliceforms of the Men1 tumor suppressor gene in mouse.
International journal of molecular medicine 2001;8(6):681-9.
2001: Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo L O
Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
Kidney international 2001;60(5):1666-75.
2001: Eriksson T; Frisk T; Gray S G; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström T J
Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
Experimental cell research 2001;270(1):88-95.
2001: Forsberg L; Villablanca A; Välimäki S; Farnebo F; Farnebo L O; Lagercrantz S; Larsson C
Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2001;145(4):415-20.
2001: Lui W O; Tanenbaum D M; Larsson C
High level amplification of 1p32-33 and 2p22-24 in small cell lung carcinomas.
International journal of oncology 2001;19(3):451-7.
2001: Kjellman P; Lagercrantz S; Höög A; Wallin G; Larsson C; Zedenius J
Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma.
Genes, chromosomes & cancer 2001;32(1):43-9.
2001: Lemmens I H; Forsberg L; Pannett A A; Meyen E; Piehl F; Turner J J; Van de Ven W J; Thakker R V; Larsson C; Kas K
Menin interacts directly with the homeobox-containing protein Pem.
Biochemical and biophysical research communications 2001;286(2):426-31.
2001: Kjellman M; Larsson C; Bäckdahl M
Genetic background of adrenocortical tumor development.
World journal of surgery 2001;25(7):948-56.
2001: Spelbrink J N; Li F Y; Tiranti V; Nikali K; Yuan Q P; Tariq M; Wanrooij S; Garrido N; Comi G; Morandi L; Santoro L; Toscano A; Fabrizi G M; Somer H; Croxen R; Beeson D; Poulton J; Suomalainen A; Jacobs H T; Zeviani M; Larsson C
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria.
Nature genetics 2001;28(3):223-31.
2001: Lui W; Wejde J; Tani E; Brosjö O; Kytölä S; Larsson C
A highly aggressive primitive mesenchymal tumor with a translocation (1;19)(q12;q13.2).
Cancer genetics and cytogenetics 2001;127(2):128-33.
2001: Frisk T; Zedenius J; Lundberg J; Wallin G; Kytölä S; Larsson C
CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome.
International journal of oncology 2001;18(6):1219-25.
2001: Nordgren A; Farnebo F; Johansson B; Holmgren G; Forestier E; Larsson C; Söderhäll S; Nordenskjöld M; Blennow E
Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping.
European journal of haematology 2001;66(5):297-304.
2001: Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.
The American journal of pathology 2001;158(5):1803-8.
2001: Rummukainen J; Kytölä S; Karhu R; Farnebo F; Larsson C; Isola J J
Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping.
Cancer genetics and cytogenetics 2001;126(1):1-7.
2001: Kjellman P; Learoyd D L; Messina M; Weber G; Höög A; Wallin G; Larsson C; Robinson B G; Zedenius J
Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome.
The British journal of surgery 2001;88(4):557-63.
2001: Li F Y; Nikali K; Gregan J; Leibiger I; Leibiger B; Schweyen R; Larsson C; Suomalainen A
Characterization of a novel human putative mitochondrial transporter homologous to the yeast mitochondrial RNA splicing proteins 3 and 4.
FEBS letters 2001;494(1-2):79-84.
2001: Kytölä S; Villablanca A; Ebeling T; Nord B; Larsson C; Höög A; Wong F K; Välimäki M; Vierimaa O; Teh B T; Salmela P I; Leisti J
Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland.
Journal of medical genetics 2001;38(3):185-9.
2001: Li F; Szobor A; Croxen R; Anselmo V; Yuan Q P; Lindblad K; Schalling M; Komoly S; Beeson D; Larsson C
Dominantly inherited familial myasthenia gravis as a separate genetic entity without involvement of defined candidate gene loci.
International journal of molecular medicine 2001;7(3):289-94.
2001: Pan Y; Lui W O; Nupponen N; Larsson C; Isola J; Visakorpi T; Bergerheim U S; Kytölä S
5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
Genes, chromosomes & cancer 2001;30(2):187-95.
2001: Ahlén J; Enberg U; Larsson C; Larsson O; Frisk T; Brosjö O; Rosen A; Bäckdahl M
Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP.
Sarcoma 2001;5(3):143-9.
2000: Edström E; Frisk T; Farnebo F; Höög A; Bäckdahl M; Larsson C
Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.
International journal of molecular medicine 2000;6(4):469-74.
2000: Gray S G; Kytölä S; Matsunaga T; Larsson C; Ekström T J
Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas.
British journal of cancer 2000;83(8):1020-5.
2000: Lindblad-Toh K; Tanenbaum D M; Daly M J; Winchester E; Lui W O; Villapakkam A; Stanton S E; Larsson C; Hudson T J; Johnson B E; Lander E S; Meyerson M
Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.
Nature biotechnology 2000;18(9):1001-5.
2000: Ki Wong F; Burgess J; Nordenskjöld M; Larsson C; Tean Teh B
Multiple endocrine neoplasia type 1.
Seminars in cancer biology 2000;10(4):299-312.
2000: Kytölä S; Farnebo F; Obara T; Isola J; Grimelius L; Farnebo L O; Sandelin K; Larsson C
Patterns of chromosomal imbalances in parathyroid carcinomas.
The American journal of pathology 2000;157(2):579-86.
2000: Nord B; Platz A; Smoczynski K; Kytölä S; Robertson G; Calender A; Murat A; Weintraub D; Burgess J; Edwards M; Skogseid B; Owen D; Lassam N; Hogg D; Larsson C; Teh B T
Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma.
International journal of cancer. Journal international du cancer 2000;87(4):463-7.
2000: Gray S G; Hartmann W; Eriksson T; Ekstrom C; Holm S; Kytola S; von Schweinitz D; Pietsch T; Larsson C; Kogner P; Sandstedt B; Ekstrom T J
Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.
International journal of molecular medicine 2000;6(2):161-9.
2000: Dwight T; Twigg S; Delbridge L; Wong F K; Farnebo F; Richardson A L; Nelson A; Zedenius J; Philips J; Larsson C; Teh B T; Robinson B
Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
Clinical endocrinology 2000;53(1):85-92.
2000: Kytölä S; Rummukainen J; Nordgren A; Karhu R; Farnebo F; Isola J; Larsson C
Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.
Genes, chromosomes & cancer 2000;28(3):308-17.
2000: Lui W O; Kytölä S; Anfalk L; Larsson C; Farnebo L O
Balanced translocation (3;7)(p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinoma?
Cancer genetics and cytogenetics 2000;119(2):109-12.
2000: Frisk T; Farnebo F; Zedenius J; Grimelius L; Höög A; Wallin G; Larsson C
Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas.
European journal of endocrinology / European Federation of Endocrine Societies 2000;142(6):643-9.
2000: Haven C J; Wong F K; van Dam E W; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips C J; Larsson C; Teh B T; Morreau H
A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.
The Journal of clinical endocrinology and metabolism 2000;85(4):1449-54.
2000: Edström E; Mahlamäki E; Nord B; Kjellman M; Karhu R; Höög A; Goncharov N; Teh B T; Bäckdahl M; Larsson C
Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.
The American journal of pathology 2000;156(2):651-9.
2000: Lemmens I H; Farnebo F; Piehl F; Merregaert J; Van de Ven W J; Larsson C; Kas K
Molecular characterization of human and murine C11orf5, a new member of the FAUNA gene cluster.
Mammalian genome : official journal of the International Mammalian Genome Society 2000;11(1):78-80.
2000: Gray S G; Kytola S; Lui W O; Larsson C; Ekstrom T J
Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma.
International journal of molecular medicine 2000;5(1):33-41.
2000: Nordgren A; Farnebo F; Björkholm M; Sahlén S; Porwit-MacDonald A; Osby E; Kytölä S; Larsson C; Nordenskjöld M; Blennow E
Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(2):95-101.
1999: Farnebo F; Svensson A; Thompson N W; Bäckdahl M; Grimelius L; Larsson C; Farnebo L O; Sandelin K
Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas.
Surgery 1999;126(6):1183-7.
1999: Teh B T; Larsson C; Nordenskjöld M
Tumor suppressor genes (TSG).
Anticancer research 1999;19(6A):4715-28.
1999: Farnebo F; Kytölä S; Teh B T; Dwight T; Wong F K; Höög A; Elvius M; Wassif W S; Thompson N W; Farnebo L O; Sandelin K; Larsson C
Alternative genetic pathways in parathyroid tumorigenesis.
The Journal of clinical endocrinology and metabolism 1999;84(10):3775-80.
1999: Li F Y; Tariq M; Croxen R; Morten K; Squier W; Newsom-Davis J; Beeson D; Larsson C
Mapping of autosomal dominant progressive external ophthalmoplegia to a 7-cM critical region on 10q24.
Neurology 1999;53(6):1265-71.
1999: Nord B; Larsson C; Wong F K; Wallin G; Teh B T; Zedenius J
Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene.
Genes, chromosomes & cancer 1999;26(1):35-9.
1999: Frisk T; Kytölä S; Wallin G; Zedenius J; Larsson C
Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization.
Genes, chromosomes & cancer 1999;25(4):349-53.
1999: Teh B T; Linblad K; Nord B; Kytölä S; Schalling M; Larsson C; Rapley E; Biggs P; Huddart R; Stratton M
Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one family.
Journal of medical genetics 1999;36(4):348-9.
1999: Ehrenborg E; Zazzi H; Lagercrantz S; Granqvist M; Hillerbrand U; Allander S V; Larsson C; Luthman H
Characterization and chromosomal localization of the human insulin-like growth factor-binding protein 6 gene.
Mammalian genome : official journal of the International Mammalian Genome Society 1999;10(4):376-80.
1999: Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim U S
Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.
Genes, chromosomes & cancer 1999;24(3):175-82.
1999: Kjellman M; Holst M; Bäckdahl M; Larsson C; Farnebo L O; Wedell A
No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours.
Clinical endocrinology 1999;50(3):343-6.
1999: Kjellman M; Enberg U; Höög A; Larsson C; Holst M; Farnebo L O; Sato H; Bäckdahl M
Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas.
World journal of surgery 1999;23(3):237-42.
1999: Wassif W S; Farnebo F; Teh B T; Moniz C F; Li F Y; Harrison J D; Peters T J; Larsson C; Harris P
Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.
Clinical endocrinology 1999;50(2):191-6.
1999: Kjellman M; Roshani L; Teh B T; Kallioniemi O P; Höög A; Gray S; Farnebo L O; Holst M; Bäckdahl M; Larsson C
Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.
The Journal of clinical endocrinology and metabolism 1999;84(2):730-5.
1999: Farnebo F; Auer G; Farnebo L O; Teh B T; Twigg S; Aspenblad U; Thompson N W; Grimelius L; Larsson C; Sandelin K
Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease.
World journal of surgery 1999;23(1):68-74.
1999: Pan Y; Kytölä S; Farnebo F; Wang N; Lui W O; Nupponen N; Isola J; Visakorpi T; Bergerheim U S; Larsson C
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
Cytogenetics and cell genetics 1999;87(3-4):225-32.
1998: Farnebo F; Höög A; Sandelin K; Larsson C; Farnebo L O
Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas.
Surgery 1998;124(6):1094-8; discussion 1098-9.
1998: Stewart C; Parente F; Piehl F; Farnebo F; Quincey D; Silins G; Bergman L; Carle G F; Lemmens I; Grimmond S; Xian C Z; Khodei S; Teh B T; Lagercrantz J; Siggers P; Calender A; Van de Vem V; Kas K; Weber G; Hayward N; Gaudray P; Larsson C
Characterization of the mouse Men1 gene and its expression during development.
Oncogene 1998;17(19):2485-93.
1998: Farnebo F; Teh B T; Kytölä S; Svensson A; Phelan C; Sandelin K; Thompson N W; Höög A; Weber G; Farnebo L O; Larsson C
Alterations of the MEN1 gene in sporadic parathyroid tumors.
The Journal of clinical endocrinology and metabolism 1998;83(8):2627-30.
1998: Teh B T; Kytölä S; Farnebo F; Bergman L; Wong F K; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1998;83(8):2621-6.
1998: Gabig T G; Crean C D; Klenk A; Long H; Copeland N G; Gilbert D J; Jenkins N A; Quincey D; Parente F; Lespinasse F; Carle G F; Gaudray P; Zhang C X; Calender A; Hoeppener J; Kas K; Thakker R V; Farnebo F; Teh B T; Larsson C; Piehl F; Lagercrantz J; Khodaei S; Carson E; Weber G
Expression and chromosomal localization of the Requiem gene.
Mammalian genome : official journal of the International Mammalian Genome Society 1998;9(8):660-5.
1998: Teh B T; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
Thymic carcinoids in multiple endocrine neoplasia type 1.
Annals of surgery 1998;228(1):99-105.
1998: Lagercrantz J; Farnebo F; Larsson C; Tvrdik T; Weber G; Piehl F
A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse.
Biochimica et biophysica acta 1998;1398(2):157-63.
1998: Höppener J W; De Wit M J; Simarro-Doorten A Y; Roijers J F; van Herrewaarden H M; Lips C J; Parente F; Quincey D; Gaudray P; Khodaei S; Weber G; Teh B; Farnebo F; Larsson C; Zhang C X; Calender A; Pannett A A; Forbes S A; Bassett J H; Thakker R V; Lemmens I; Van de Ven W J; Kas K
A putative human zinc-finger gene (ZFPL1) on 11q13, highly conserved in the mouse and expressed in exocrine pancreas. The European Consortium on MEN 1.
Genomics 1998;50(2):251-9.
1998: Bajalica-Lagercrantz S; Piehl F; Farnebo F; Larsson C; Lagercrantz J
Expression of the BCL6 gene in the pre- and postnatal mouse.
Biochemical and biophysical research communications 1998;247(2):357-60.
1998: Teh B T; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong F K; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo L O; Larsson C
Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.
The Journal of clinical endocrinology and metabolism 1998;83(6):2114-20.
1998: Betz R; Leibiger B; Farnebo F; Lagercrantz S; Piehl F; Leibiger I; Larsson C
Mapping of the human Ca2+ channel beta 4 subunit to 2q22-23 and its expression in developing mouse.
Mammalian genome : official journal of the International Mammalian Genome Society 1998;9(4):310-1.
1998: Teh B T; Blennow E; Giraud S; Sahlén S; Hii S I; Brookwell R; Brauch H; Nordenskjöld M; Larsson C; Nicol D
Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution.
Genes, chromosomes & cancer 1998;21(3):260-4.
1998: Phelan C M; Borg A; Cuny M; Crichton D N; Baldersson T; Andersen T I; Caligo M A; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon Y J; Scherneck S; Barkardottir R; Borresen-Dale A L; Eyfjörd J; Theillet C; Thompson A M; Larsson C
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Cancer research 1998;58(5):1004-12.
1998: Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim U S
Identification of two distinct deleted regions on chromosome 13 in prostate cancer.
Oncogene 1998;16(4):481-7.
1998: Zedenius J; Dwight T; Robinson B G; Delbridge L; Bäckdahl M; Wallin G; Larsson C; Weber G
A rapid method for DNA extraction from fine-needle aspiration biopsies of thyroid tumors, and subsequent RET mutation analysis.
Cancer detection and prevention 1998;22(6):544-8.
1997: Ernstsson S; Betz R; Lagercrantz S; Larsson C; Ericksson S; Cederberg A; Carlsson P; Enerbäck S
Cloning and characterization of freac-9 (FKHL17), a novel kidney-expressed human forkhead gene that maps to chromosome 1p32-p34.
Genomics 1997;46(1):78-85.
1997: Dahia P L; Marsh D J; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
Cancer research 1997;57(21):4710-3.
1997: Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo L O
Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1997;82(10):3481-6.
1997: Cederberg A; Betz R; Lagercrantz S; Larsson C; Hulander M; Carlsson P; Enerbäck S
Chromosome localization, sequence analysis, and expression pattern identify FKHL 18 as a novel human forkhead gene.
Genomics 1997;44(3):344-6.
1997: Forbes S A; Pannett A A; Bassett J H; Harding B; Wooding C; Thakker R V; Butler R; Ogilvie D; Anand R; Gaudray P; Weber G; Larsson C; Zhang C X; Calender A; Höppener J W; Lips C J; Kas K
Mapping of the gene encoding the B56 beta subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).
Human genetics 1997;100(3-4):481-5.
1997: Farnebo F; Farnebo L O; Nordenström J; Larsson C
Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism.
The European journal of surgery = Acta chirurgica 1997;163(5):331-7.
1997: Teh B T; Giraud S; Sari N F; Hii S I; Bergerat J P; Larsson C; Limacher J M; Nicol D
Familial non-VHL non-papillary clear-cell renal cancer.
Lancet 1997;349(9055):848-9.
1997: Farnebo F; Teh B T; Dotzenrath C; Wassif W S; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo L O; Larsson C
Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Human genetics 1997;99(3):342-9.
1997: Teh B T; Sullivan A A; Farnebo F; Zander C; Li F Y; Strachan N; Schalling M; Larsson C; Sandstrom P
Oculopharyngeal muscular dystrophy (OPMD)--report and genetic studies of an Australian kindred.
Clinical genetics 1997;51(1):52-5.
1997: Teh B T; McArdle J; Chan S P; Menon J; Hartley L; Pullan P; Ho J; Khir A; Wilkinson S; Larsson C; Cameron D; Shepherd J
Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.
Medicine 1997;76(1):21-9.
1997: Weber G; Grimmond S; Lagercrantz J; Friedman E; Phelan C; Carson E; Hayward N; Jacobovitz O; Nordenskjöld M; Larsson C
Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1.
Human genetics 1997;99(1):130-2.
1997: Farnebo F; Järhult J; Farnebo L O; Nilsson O; Teh B T; Lagercrantz J; Weber G; Sandelin K; Larsson C
Multiple endocrine neoplasia type 1 and the search for the genetic trigger.
Hormone research 1997;47(4-6):179-84.
1996: Teh B T; Farnebo F; Kristoffersson U; Sundelin B; Cardinal J; Axelson R; Yap A; Epstein M; Heath H; Cameron D; Larsson C
Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.
The Journal of clinical endocrinology and metabolism 1996;81(12):4204-11.
1996: Courseaux A; Grosgeorge J; Gaudray P; Pannett A A; Forbes S A; Williamson C; Bassett D; Thakker R V; Teh B T; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang C X; Salandre J; Calender A
Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).
Genomics 1996;37(3):354-65.
1996: Teh B T; McArdle J; Parameswaran V; David R; Larsson C; Shepherd J
Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1.
Archives of surgery (Chicago, Ill. : 1960) 1996;131(11):1230-2.
1996: Kjellman M; Kallioniemi O P; Karhu R; Höög A; Farnebo L O; Auer G; Larsson C; Bäckdahl M
Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.
Cancer research 1996;56(18):4219-23.
1996: Dotzenrath C; Teh B T; Farnebo F; Cupisti K; Svensson A; Toell A; Goretzki P; Larsson C
Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?
The Journal of clinical endocrinology and metabolism 1996;81(9):3194-6.
1996: Lancaster J M; Wooster R; Mangion J; Phelan C M; Cochran C; Gumbs C; Seal S; Barfoot R; Collins N; Bignell G; Patel S; Hamoudi R; Larsson C; Wiseman R W; Berchuck A; Iglehart J D; Marks J R; Ashworth A; Stratton M R; Futreal P A
BRCA2 mutations in primary breast and ovarian cancers.
Nature genetics 1996;13(2):238-40.
1996: Phelan C M; Lancaster J M; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher M C; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod S A; Futreal P A
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Nature genetics 1996;13(1):120-2.
1996: Phelan C M; Larsson C; Baird S; Futreal P A; Ruttledge M H; Morgan K; Tonin P; Hung H; Korneluk R G; Pollak M N; Narod S A
The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.
Genomics 1996;34(1):63-8.
1996: Heath H; Odelberg S; Jackson C E; Teh B T; Hayward N; Larsson C; Buist N R; Krapcho K J; Hung B C; Capuano I V; Garrett J E; Leppert M F
Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.
The Journal of clinical endocrinology and metabolism 1996;81(4):1312-7.
1996: Zedenius J; Wallin G; Svensson A; Bovèe J; Höög A; Bäckdahl M; Larsson C
Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors.
Human genetics 1996;97(3):299-303.
1996: Lagercrantz J; Larsson C; Grimmond S; Fredriksson M; Weber G; Piehl F
Expression of the VEGF-related factor gene in pre- and postnatal mouse.
Biochemical and biophysical research communications 1996;220(1):147-52.
1996: Phelan C M; Rebbeck T R; Weber B L; Devilee P; Ruttledge M H; Lynch H T; Lenoir G M; Stratton M R; Easton D F; Ponder B A; Cannon-Albright L; Larsson C; Goldgar D E; Narod S A
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Nature genetics 1996;12(3):309-11.
1996: Lagercrantz J; Carson E; Larsson C; Nordenskjöld M; Weber G
Isolation and characterization of a novel gene close to the human phosphoinositide-specific phospholipase C beta 3 gene on chromosomal region 11q13.
Genomics 1996;31(3):380-4.
1996: Zedenius J; Larsson C; Wallin G; Bäckdahl M; Aspenblad U; Höög A; Børresen A L; Auer G
Alterations of p53 and expression of WAF1/p21 in human thyroid tumors.
Thyroid : official journal of the American Thyroid Association 1996;6(1):1-9.
1996: Zedenius J; Ståhle-Bäckdahl M; Enberg U; Grimelius L; Larsson C; Wallin G; Bäckdahl M
Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA.
World journal of surgery 1996;20(1):101-6.
1996: Dotzenrath C; Goretzki P E; Farnebo F; Teh B T; Weber G; Röher H D; Larsson C
Molecular genetics of primary and secondary hyperparathyroidism.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1996;104 Suppl 4():105-7.
1995: Larsson C; Hellqvist M; Pierrou S; White I; Enerbäck S; Carlsson P
Chromosomal localization of six human forkhead genes, freac-1 (FKHL5), -3 (FKHL7), -4 (FKHL8), -5 (FKHL9), -6 (FKHL10), and -8 (FKHL12).
Genomics 1995;30(3):464-9.
1995: Lagercrantz J; Piehl F; Nordenskjold M; Larsson C; Weber G
Expression of the phosphoinositide-specific phospholipase Cbeta3 gene in the rat.
Neuroreport 1995;6(18):2542-4.
1995: Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
The Journal of clinical endocrinology and metabolism 1995;80(10):3088-90.
1995: Teh B T; Grimmond S; Shepherd J; Larsson C; Hayward N
Multiple endocrine neoplasia type I: clinical syndrome to molecular genetics.
The Australian and New Zealand journal of surgery 1995;65(10):708-13.
1995: Teh B T; Cardinal J; Shepherd J; Hayward N K; Weber G; Cameron D; Larsson C
Genetic mapping of the multiple endocrine neoplasia type 1 locus at 11q13.
Journal of internal medicine 1995;238(3):249-53.
1995: Lagercrantz J; Larsson C; Grimmond S; Skogseid B; Gobl A; Friedman E; Carson E; Phelan C; Oberg K; Nordenskjöld M
Candidate genes for multiple endocrine neoplasia type 1.
Journal of internal medicine 1995;238(3):245-8.
1995: Larsson C; Calender A; Grimmond S; Giraud S; Hayward N K; Teh B; Farnebo F
Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1.
Journal of internal medicine 1995;238(3):239-44.
1995: Courseaux A; Grosgeorge J; Garnier G; Larsson C; Ayraud N; Gaudray P; Raynaud S D
Rearrangement of proximal 11q13 band in a CMML in acute transformation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(8):1313-7.
1995: Zedenius J; Wallin G; Svensson A; Grimelius L; Höög A; Lundell G; Bäckdahl M; Larsson C
Allelotyping of follicular thyroid tumors.
Human genetics 1995;96(1):27-32.
1995: Teh B T; Silburn P; Lindblad K; Betz R; Boyle R; Schalling M; Larsson C
Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13.
American journal of human genetics 1995;56(6):1443-9.
1995: Huynh H T; Larsson C; Narod S; Pollak M
Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.
Cancer research 1995;55(11):2225-31.
1995: Lagercrantz J; Carson E; Phelan C; Grimmond S; Rosén A; Daré E; Nordenskjöld M; Hayward N K; Larsson C; Weber G
Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C beta 3 gene (PLCB3).
Genomics 1995;26(3):467-72.
1995: Grimmond S; Weber G; Larsson C; Walters M; Teh B; Shepherd J; Nordenskjold M; Hayward N
Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1.
Human genetics 1995;95(4):455-8.
1995: Larsson C; White I; Johansson C; Stark A; Meijer J
Localization of the human soluble epoxide hydrolase gene (EPHX2) to chromosomal region 8p21-p12.
Human genetics 1995;95(3):356-8.
1994: Larsson C; Lardelli M; White I; Lendahl U
The human NOTCH1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation.
Genomics 1994;24(2):253-8.
1994: Larsson C; Weber G; Teh B T; Lagercrantz J
Genetics of multiple endocrine neoplasia type 1.
Annals of the New York Academy of Sciences 1994;733():453-63.
1994: Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
Human molecular genetics 1994;3(8):1259-62.
1994: Larsson C; Nordenskjöld M
Family screening in multiple endocrine neoplasia type 1 (MEN 1).
Annals of medicine 1994;26(3):191-8.
1994: Blennow E; Telenius H; de Vos D; Larsson C; Henriksson P; Johansson O; Carter N P; Nordenskjöld M
Tetrasomy 15q: two marker chromosomes with no detectable alpha-satellite DNA.
American journal of human genetics 1994;54(5):877-83.
1994: Lindblom A; Sandelin K; Iselius L; Dumanski J; White I; Nordenskjöld M; Larsson C
Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.
American journal of human genetics 1994;54(5):871-6.
1994: Allander S V; Larsson C; Ehrenborg E; Suwanichkul A; Weber G; Morris S L; Bajalica S; Kiefer M C; Luthman H; Powell D R
Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5.
The Journal of biological chemistry 1994;269(14):10891-8.
1994: Larsson C; Friedman E
Localization and identification of the multiple endocrine neoplasia type 1 disease gene.
Endocrinology and metabolism clinics of North America 1994;23(1):67-79.
1994: Friedman E; Adams E F; Höög A; Gejman P V; Carson E; Larsson C; De Marco L; Werner S; Fahlbusch R; Nordenskjöld M
Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors.
The Journal of clinical endocrinology and metabolism 1994;78(3):568-74.
1994: Sandelin K; Larsson C; Decker R A
Genetic aspects of multiple endocrine neoplasia types 1 and 2.
Current opinion in general surgery 1994;():60-8.
1993: Wassif W S; Moniz C F; Friedman E; Wong S; Weber G; Nordenskjöld M; Peters T J; Larsson C
Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer.
The Journal of clinical endocrinology and metabolism 1993;77(6):1485-9.
1993: Friedman E; Carson E; Larsson C; DeMarco L
A polymorphism in the coding region of the vasopressin type 2 receptor (AVPR2) gene.
Human molecular genetics 1993;2(10):1746.
1993: Karlbom A E; James C D; Boethius J; Cavenee W K; Collins V P; Nordenskjöld M; Larsson C
Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.
Human genetics 1993;92(2):169-74.
1993: Lindblom A; Skoog L; Rotstein S; Werelius B; Larsson C; Nordenskjöld M
Loss of heterozygosity in familial breast carcinomas.
Cancer research 1993;53(18):4356-61.
1993: Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
Cancer research 1993;53(16):3707-11.
1993: Lindblom A; Rotstein S; Nordenskjöld M; Larsson C
Linkage analysis with markers on 17q in 29 Swedish breast cancer families.
American journal of human genetics 1993;52(4):749-53.
1993: Lindblom A; Skoog L; Andersen T I; Rotstein S; Nordenskjöld M; Larsson C
Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.
Human genetics 1993;91(1):6-12.
1993: Allander S V; Bajalica S; Larsson C; Luthman H; Powell D R; Stern I; Weber G; Zazzi H; Ehrenborg E
Structure and chromosomal localization of human insulin-like growth factor-binding protein genes.
Growth regulation 1993;3(1):3-5.
1992: Blennow E; Telenius H; Larsson C; de Vos D; Bajalica S; Ponder B A; Nordenskjöld M
Complete characterization of a large marker chromosome by reverse and forward chromosome painting.
Human genetics 1992;90(4):371-4.
1992: Ehrenborg E; Larsson C
An EcoRI RFLP at the human insulin-like growth factor binding protein 2 gene (IGFBP2).
Human molecular genetics 1992;1(7):552.
1992: Bajalica S; Allander S V; Ehrenborg E; Brøndum-Nielsen K; Luthman H; Larsson C
Localization of the human insulin-like growth-factor-binding protein 4 gene to chromosomal region 17q12-21.1.
Human genetics 1992;89(2):234-6.
1992: Larsson C; Weber G; Kvanta E; Lewis K; Janson M; Jones C; Glaser T; Evans G; Nordenskjöld M
Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus.
Human genetics 1992;89(2):187-93.
1992: Sandelin K; Larsson C; Falkmer U G; Farnebo L O; Grimelius L; Nordenskjöld M
Morphology, DNA ploidy and allele losses on chromosome 11 in sporadic hyperparathyroidism and that associated with multiple neoplasia, type 1.
The European journal of surgery = Acta chirurgica 1992;158(4):199-206.
1992: Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
The Journal of clinical investigation 1992;89(4):1344-9.
1992: Ehrenborg E; Larsson C; Stern I; Janson M; Powell D R; Luthman H
Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7.
Genomics 1992;12(3):497-502.
1992: Larsson C; Nordenskjold M; Skogseid B; Oberg K
Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.
Henry Ford Hospital medical journal 1992;40(3-4):173-6.
1992: Larsson C; Weber G; Janson M
Sublocalization of the multiple endocrine neoplasia type 1 gene.
Henry Ford Hospital medical journal 1992;40(3-4):159-61.
1991: Carlbom E; Sugawa N; Larsson C; Scambler P J; Dumanski J P; Collins V P; Nordenskjöld M
Identification of twelve new RFLP-markers on chromosome 22q11-qter.
Human genetics 1991;88(2):135-8.
1991: Janson M; Larsson C; Werelius B; Jones C; Glaser T; Nakamura Y; Jones C P; Nordenskjöld M
Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10609-13.
1991: Ehrenborg E; Vilhelmsdotter S; Bajalica S; Larsson C; Stern I; Koch J; Brøndum-Nielsen K; Luthman H
Structure and localization of the human insulin-like growth factor-binding protein 2 gene.
Biochemical and biophysical research communications 1991;176(3):1250-5.
1990: Larsson C; Byström C; Skoog L; Rotstein S; Nordenskjöld M
Genomic alterations in human breast carcinomas.
Genes, chromosomes & cancer 1990;2(3):191-7.
1990: Byström C; Larsson C; Blomberg C; Sandelin K; Falkmer U; Skogseid B; Oberg K; Werner S; Nordenskjöld M
Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(5):1968-72.
1990: Larsson C; Nordenskjöld M
Multiple endocrine neoplasia.
Cancer surveys 1990;9(4):703-23.
1989: Nordenskjöld M; Larsson C; Oberg K; Nakamura Y
Mapping of the gene for multiple endocrine neoplasia type I to chromosome 11q13.
Pathologie-biologie 1989;37(9):951.
1989: Nakamura Y; Larsson C; Julier C; Byström C; Skogseid B; Wells S; Oberg K; Carlson M; Taggart T; O'Connell P
Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11.
American journal of human genetics 1989;44(5):751-5.
1988: Larsson C; Skogseid B; Oberg K; Nakamura Y; Nordenskjöld M
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.
Nature 1988;332(6159):85-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Catharina Larsson

Research Profile (preview)

Procedures

Anatomy

Disorders

Phenomena

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Catharina Larsson (preview)

All Publications